Israel's Actions in Syria, Gaza Surprised Trump amid Growing Frustration with Netanyahu
The remarks refer to Israel's bombing of government buildings in Damascus last week, in response to clashes that erupted in Syria's Sweida southern province between security forces, Druze armed groups and Bedouin tribes. They also refer to an Israeli strike on the only Catholic Church in Gaza, which killed 3 people.
Both incidents prompted Trump to speak with the Israeli Prime Minister, Benjamin Netanyahu, to 'rectify' the situations, suggesting growing alarm over Israeli policies that could undermine Trump's agenda for the region. Surprising Actions
Speaking to reporters at the White House on Monday, Press Secretary, Karoline Leavitt, said: 'The president enjoys a good working relationship with Bibi Netanyahu, and stays in frequent communication with him. He was caught off guard by the bombing in Syria and also the bombing of a Catholic Church in Gaza,' reported CNN.
'In both accounts, the president quickly called the prime minister to rectify those situations,' Leavitt added, in a signal that Trump was unhappy with Israel's actions in Syria and Gaza. Israeli Strikes in Syria
Against the backdrop of Sweida clashes, Israel intervened under the pretext of protecting the Druze community, launching airstrikes against Syrian government troops and convoys on Tuesday, and targeting the Syrian Defense Ministry headquarters and near the presidential palace in the heart of Damascus on Wednesday. It also threatened the Syrian government with a tougher response if it did not pull its troops from Sweida.
On Saturday, the US Special Envoy for Syria, Tom Barrack, announced a ceasefire agreement between the Syrian government and Israel, supported by the US and embraced by Türkiye, Jordan and other countries in the region. Bombing Gaza Church
Furthermore, Israel on Thursday morning struck the Holy Family Church, the only Catholic church in Gaza, sparking worldwide denunciation and an immediate negative reaction from Trump. The US President called Netanyahu to express disappointment and urge him to issue a statement on the incident.
As a result, the Israeli Prime Minister released a statement voicing Israel's regret over the strike and saying it was by mistake. 'Israel deeply regrets that a stray ammunition hit Gaza's Holy Family Church,' he said, adding that Israel is investigating the incident. Undermining Efforts in Syria
Trump has thrown his support behind the Syrian Transitional President, Ahmed Al-Sharaa, lifting the decades-old sanctions against the country and tasking the US Secretary of State, Marco Rubio, with making efforts to calm tensions in Syria.
The US President's efforts aim to 'support the country's path to stability and peace' and 'give them a chance at greatness.' He first announced the decision to lift Syria's sanctions during his landmark visit to Riyadh in May 2025.
Israel's strikes in Syria came as Al-Sharaa's administration is working to rebuild the nation, battered by more than a decade of civil war. Concerns over Gaza
With regards to Gaza, Trump hoped that Netanyahu's visit to Washington earlier in July would yield progress on a ceasefire agreement that would release the remaining hostages and bring the war to an end. Despite Trump's repeated remarks that signaled optimism regarding reaching a deal that week, the Israeli Prime Minister left the US without announcing a deal.
The situation in Gaza has raised Trump's concerns, as the civilian death toll is mounting. In the light of this, Leavitt said: 'The president's message on this conflict we've seen in the Middle East taking place for far too long, that has become quite brutal, especially in recent days, you've seen reports of more people dying. I think the president never likes to see that. He wants the killing to end.' Behind the Scenes
Trump and Netanyahu appear to enjoy warm relations. The US President agreed to join Israel in its campaign on Iran in June, striking Tehran's key nuclear sites. Meanwhile, Netanyahu said he would nominate Trump for the Nobel Peace Prize.
However, the relationship between Trump and Netanyahu is complicated. Despite being strong allies, they do not enjoy close personal ties and their relation has been marked by mutual distrust at times, sources familiar with the matter told CNN.
Similarly, Axios quoted six American officials as pointing to growing frustration within the Trump administration with Netanyahu over his recent actions in Syria and Gaza, with some warning that the two men's relation could deteriorate further, amid a growing sense that Netanyahu's actions could undermine Trump's agenda.
Short link :
Post Views: 7
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Al Arabiya
28 minutes ago
- Al Arabiya
Syrian, Israeli ministers will hold a meeting in Baku on Thursday: Diplomat
Syrian and Israeli ministers will hold a meeting in the Azerbaijani capital Baku on Thursday, AFP reports citing a diplomat.
Al Arabiya
an hour ago
- Al Arabiya
FDA vaccine chief leaving agency after less than three months
The Food and Drug Administration's polarizing vaccine chief is leaving the agency after a brief tenure that drew the ire of biotech companies, patient groups, and conservative allies of President Donald Trump. Dr. Vinay Prasad did not want to be a distraction and was stepping down from his role as the FDA's top vaccine regulator to spend more time with his family, a spokesperson for the Department of Health and Human Services said in a statement late Tuesday. Two people familiar with the situation told The Associated Press that Prasad was ousted following several recent controversies. The people spoke on condition of anonymity to discuss internal personnel matters. Prasad joined the FDA in May after years as an academic researcher at the University of California, San Francisco, where he frequently criticized the FDA's approach to drug approvals and COVID-19 vaccines. His contrarian approach appeared to match FDA Commissioner Marty Makary, who repeatedly praised Prasad's work and intellect. But in recent weeks, Prasad became a target of conservative activists, including Laura Loomer, who flagged Prasad's past statements criticizing Trump and praising liberal independent Senator Bernie Sanders. 'How did this Trump-hating Bernie Bro get into the Trump admin???' Loomer posted on X last week. Prasad also attracted scrutiny for his handling of a recent safety issue surrounding the only approved gene therapy for Duchennes muscular dystrophy. Under his direction, shipments of the therapy were briefly halted after a series of patient deaths, then resumed late Monday following vocal pushback from families of boys with the fatal muscle-wasting disorder. Prasad has long been skeptical of the therapy and other muscular dystrophy drugs sold by the drugmaker Sarepta Therapeutics. As an academic, Prasad gained prominence by attacking the FDA for being too lenient in its standards for approving cancer drugs and other new therapies. That approach is at odds with Trump's Republican supporters, who generally favor speedier approvals and unfettered access to experimental treatments. During Trump's first term, he signed the 'Right to Try' law, a largely symbolic piece of legislation that won popular support from conservatives seeking to give dying patients expanded access to unproven drugs. Prasad's decision to pause Sarepta's therapy was criticized last week by a columnist and the editorial board of The Wall Street Journal. Separately, Prasad's division issued rejection letters this month to three small biotech firms seeking approval for new gene therapies. Prasad's predecessor in the role, Dr. Peter Marks, oversaw a steep rise in approvals for new gene therapies, which aim to treat or prevent disease by replacing or modifying a portion of patients' genetic code. Prasad has been an outspoken critic of Marks' leadership at FDA, which included overseeing the approval of the first COVID vaccines and therapies.
Al Arabiya
2 hours ago
- Al Arabiya
US to impose 25 pct tariff on India from August 1: Trump
President Donald Trump said on Wednesday the United States will impose a 25 percent tariff on goods imported from India starting on Aug. 1. He said India, which has the world's fifth largest economy, will also face an unspecified penalty on Aug. 1, but did not elaborate on the amount or what it was for. 'While India is our friend, we have, over the years, done relatively little business with them because their Tariffs are far too high, among the highest in the World, and they have the most strenuous and obnoxious non-monetary Trade Barriers of any Country,' Trump wrote in a Truth Social post. 'They have always bought a vast majority of their military equipment from Russia, and are Russia's largest buyer of ENERGY, along with China, at a time when everyone wants Russia to STOP THE KILLING IN UKRAINE — ALL THINGS NOT GOOD!' India's commerce ministry, which is leading the trade negotiations with the United States, did not immediately respond to a request for comment. Trump's decision dashes hopes of a limited trade agreement between the two countries, which had been under negotiation for several months. US and Indian trade negotiators had held multiple rounds of discussions to resolve contentious issues, particularly over market access for American agricultural and dairy products. Despite progress in some areas, Indian officials resisted opening the domestic market to imports of wheat, corn, rice and genetically modified soybeans, citing risks to the livelihood of millions of Indian farmers. The new tariffs are expected to impact India's goods exports to the US, estimated at around $87 billion in 2024, including labor-intensive products such as garments, pharmaceuticals, gems and jeweler, and petrochemicals. The United States currently has a $45.7 billion trade deficit with India. India now joins a growing list of countries facing higher tariffs under Trump's 'Liberation Day' trade policy, aimed at reshaping US trade relations by demanding greater reciprocity. The White House had previously warned India about its high average applied tariffs — nearly 39 percent on agricultural products, with rates climbing to 45 percent on vegetable oils and around 50 percent on apples and corn. The setback comes despite earlier commitments by Prime Minister Narendra Modi and Trump to conclude the first phase of a trade deal by autumn 2025 and expand bilateral trade to $500 billion by 2030, up from $191 billion in 2024.
